IMMUNOVANT SCIENCES LTD
Summary
Immunovant is a clinical-stage biopharmaceutical company focused on enabling normal lives for patients with autoimmune diseases.
Deals Overview
Total Deals2
Valued Deals2
Total Value£ 466 M
Avg. Deal Size£ 233 M
Senior Management
Pete Salzmann
CEO
Tom Dorney
Communications Director
By continuing, you agree to our Terms & Conditions and our Data Privacy Policy
All rights reserved. Copyright © 2025 Datasite